Search research articles
Contact Us
Filters
Showing results (1-10 of 181) with videos related to
Page
of 19
Sort By:
The Oncologist
|
June 22, 2021
Regarding HER2-Amplified Biliary Tract Cancer
Shubham Pant
Drugs of Today (Barcelona, Spain : 1998)
|
April 4, 2009
Association of major stressors with elevated risk of breast cancer incidence or relapse
Shubham Pant, Bhuvaneswari Ramaswamy
Advances in Experimental Medicine and Biology
|
January 1, 2022
Immunotherapy in Gastrointestinal Malignancies
Rishi Surana, Shubham Pant
Advances in Experimental Medicine and Biology
|
April 18, 2020
Immunotherapy in Gastrointestinal Malignancies
Jonathan Mizrahi, Shubham Pant
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|
April 30, 2021
Personalizing Medicine With Germline and Somatic Sequencing in Advanced Pancreatic Cancer: Current Treatments and Novel Opportunities
Michael S Lee, Shubham Pant
Drugs
|
December 20, 2008
Aromatase inhibitor-associated bone loss: clinical considerations
Shubham Pant, Charles L Shapiro
Oncology (Williston Park, N.Y.)
|
October 22, 2020
Barriers to Pancreatic Clinical Trials Enrollment
Shubham Pant, Michael S Lee
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
July 21, 2007
Hematopoietic stem cell transplantation in multiple myeloma
Shubham Pant, Edward A Copelan
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners
|
March 15, 2014
Recurrent metastatic anal cancer treated with modified paclitaxel, ifosfamide, and cisplatin and third-line mitomycin/cetuximab
Mohamad Khawandanah, Allison Baxley, Shubham Pant
Nature Reviews. Clinical Oncology
|
July 24, 2019
PARP inhibition - opportunities in pancreatic cancer
Shubham Pant, Anirban Maitra, Timothy A Yap
Page
of 19
Search research articles
Search
Showing results (1-10 of 181) with videos related to
Sort By:
Page
of 19
The Oncologist
|
June 22, 2021
Regarding HER2-Amplified Biliary Tract Cancer
Shubham Pant
Drugs of Today (Barcelona, Spain : 1998)
|
April 4, 2009
Association of major stressors with elevated risk of breast cancer incidence or relapse
Shubham Pant, Bhuvaneswari Ramaswamy
Advances in Experimental Medicine and Biology
|
January 1, 2022
Immunotherapy in Gastrointestinal Malignancies
Rishi Surana, Shubham Pant
Advances in Experimental Medicine and Biology
|
April 18, 2020
Immunotherapy in Gastrointestinal Malignancies
Jonathan Mizrahi, Shubham Pant
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|
April 30, 2021
Personalizing Medicine With Germline and Somatic Sequencing in Advanced Pancreatic Cancer: Current Treatments and Novel Opportunities
Michael S Lee, Shubham Pant
Drugs
|
December 20, 2008
Aromatase inhibitor-associated bone loss: clinical considerations
Shubham Pant, Charles L Shapiro
Oncology (Williston Park, N.Y.)
|
October 22, 2020
Barriers to Pancreatic Clinical Trials Enrollment
Shubham Pant, Michael S Lee
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
July 21, 2007
Hematopoietic stem cell transplantation in multiple myeloma
Shubham Pant, Edward A Copelan
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners
|
March 15, 2014
Recurrent metastatic anal cancer treated with modified paclitaxel, ifosfamide, and cisplatin and third-line mitomycin/cetuximab
Mohamad Khawandanah, Allison Baxley, Shubham Pant
Nature Reviews. Clinical Oncology
|
July 24, 2019
PARP inhibition - opportunities in pancreatic cancer
Shubham Pant, Anirban Maitra, Timothy A Yap
Page
of 19